The PROMISE I early feasibility study demonstrated a 12-month amputation-free survival rate of 76% in patients who would otherwise face certain amputation. The ALPS Multicenter Study showed similarly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results